Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
0.900
+0.100 (12.50%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Arch Therapeutics Statistics

Total Valuation

ARTH has a market cap or net worth of $500,006. The enterprise value is $8.53 million.

Market Cap 500,006
Enterprise Value 8.53M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

ARTH has 555,562 shares outstanding. The number of shares has increased by 255.94% in one year.

Shares Outstanding 555,562
Shares Change (YoY) +255.94%
Shares Change (QoQ) -4.47%
Owned by Insiders (%) 3.51%
Owned by Institutions (%) 3.38%
Float 4.30M

Valuation Ratios

PE Ratio n/a
Forward PE 0.08
PS Ratio 3.83
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 65.35
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.12

Current Ratio 0.12
Quick Ratio 0.00
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.62

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -547.45%
Return on Capital (ROIC) n/a
Revenue Per Employee $16,318
Profits Per Employee -$1.05M
Employee Count 8
Asset Turnover 0.07
Inventory Turnover 0.06

Taxes

Income Tax -1.49M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.25% in the last 52 weeks. The beta is 3.61, so ARTH's price volatility has been higher than the market average.

Beta (5Y) 3.61
52-Week Price Change -53.25%
50-Day Moving Average 1.01
200-Day Moving Average 2.51
Relative Strength Index (RSI) 49.38
Average Volume (20 Days) 1,830

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, ARTH had revenue of $130,543 and -$8.43 million in losses. Loss per share was -$2.84.

Revenue 130,543
Gross Profit 43,572
Operating Income -4.71M
Pretax Income -8.43M
Net Income -8.43M
EBITDA -4.71M
EBIT -4.71M
Loss Per Share -$2.84
Full Income Statement

Balance Sheet

The company has $26,426 in cash and $8.06 million in debt, giving a net cash position of -$8.03 million or -$14.46 per share.

Cash & Cash Equivalents 26,426
Total Debt 8.06M
Net Cash -8.03M
Net Cash Per Share -$14.46
Equity (Book Value) -10.88M
Book Value Per Share -19.58
Working Capital -10.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.69 million and capital expenditures -$4,521, giving a free cash flow of -$3.69 million.

Operating Cash Flow -3.69M
Capital Expenditures -4,521
Free Cash Flow -3.69M
FCF Per Share -$0.82
Full Cash Flow Statement

Margins

Gross margin is 33.38%, with operating and profit margins of -3,611.58% and -6,458.48%.

Gross Margin 33.38%
Operating Margin -3,611.58%
Pretax Margin -6,458.48%
Profit Margin -6,458.48%
EBITDA Margin -3,609.95%
EBIT Margin -3,611.58%
FCF Margin -2,827.86%

Dividends & Yields

ARTH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -255.94%
Shareholder Yield -255.94%
Earnings Yield -1,686.20%
FCF Yield -738.31%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on January 18, 2023. It was a reverse split with a ratio of 1:200.

Last Split Date Jan 18, 2023
Split Type Reverse
Split Ratio 1:200

Scores

ARTH has an Altman Z-Score of -78.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -78.66
Piotroski F-Score 3